XML 78 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Compensation and Other Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2013
Compensation and Other Benefit Plans [Abstract]  
Stock option activity
A summary of the status of the Company’s stock option plans as of December 31, 2013, 2012, and 2011, and changes during the years ended on those dates is presented below:

   
2013
  
2012
  
2011
 
Options:
 
Shares
  
Price*
  
Shares
  
Price*
  
Shares
  
Price*
 
Outstanding at beginning of year
  6,788,383  $8.99   5,053,435  $12.55   2,331,450  $25.36 
                          
Granted
  1,168,203  $3.13   2,351,445  $2.59   2,920,166  $2.81 
Exercised
  (589,355) $2.26   (90,252) $1.68   -  $- 
Forfeited, expired or cancelled
  (151,190) $17.46   (526,245) $15.84   (198,181) $35.56 
                          
Outstanding at end of year
  7,216,041  $8.42   6,788,383  $8.99   5,053,435  $12.55 
                          
Exercisable at end of year
  4,814,926  $11.14   4,276,834  $12.42   3,366,807  $16.33 

*
Weighted-average exercise price

Unvested RSU activity
Unvested RSU activity for the year ended December 31, 2013 is summarized below:
 
   
Number of
Shares
  
Weighted-
Average Grant-
Date Fair Value
 
Unvested balance at December 31, 2012
  1,459,853  $2.75 
Granted
  958,385  $2.96 
Vested
  (637,034) $2.57 
Forfeited
  (43,167) $2.08 
Unvested balance at December 31, 2013
  1,738,037  $2.73 
 
Weighted average assumptions
The fair value of stock option awards was estimated using the Black-Scholes model with the following weighted average assumptions for the years ended December 31, 2013, 2012, and 2011:

   
Year Ended December 31,
 
   
2013
  
2012
  
2011
 
Dividend yield
  0%  0%  0%
Expected volatility
  92%  92%  88%
Risk-free interest rate
  0.89%  0.82%  1.48%
Expected term
 
5.6 years
  
5.6 years
  
5.4 years
 

Stock-based compensation expense
The following table shows total stock-based compensation expense included in the consolidated statements of comprehensive loss for the years ended December 31, 2013, 2012, and 2011 (in thousands):

   
Year Ended December 31,
 
   
2013
  
2012
  
2011
 
Research and development
 $2,358  $2,391  $3,672 
Selling, general and administrative
  2,741   1,893   4,087 
Total stock-based compensation expense
 $5,099  $4,284  $7,759